BioCardia Inc BCDA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
3.34quote price arrow down-0.16 (-4.57%)
Volume
324
Close
3.50quote price arrow up+0.08 (+2.34%)
Volume
158,118
52 week range
1.91 - 8.60

...

Loading . . .

KEY STATS

  • Open3.42
  • Day High3.52
  • Day Low3.10
  • Prev Close3.42
  • 52 Week High8.60
  • 52 Week High Date12/15/20
  • 52 Week Low1.91
  • 52 Week Low Date11/06/20
  • Market Cap50.65M
  • Shares Out14.47M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • 1 Year % Change-18.22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.96
  • P/E (TTM)-1.79
  • Fwd P/E (NTM)-3.38
  • EBITDA (MRQ)-15.473M
  • ROE (MRQ)-333.43%
  • Revenue (MRQ)310,000.00
  • Gross Margin (MRQ)76.11%
  • Net Margin (MRQ)-4,941.40%
  • Debt To Equity (MRQ)12.38%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BioCardia Inc News

There is no recent news for this security.

Latest BCDA News From Our Partners

QUOTE FINDER

Profile

MORE
BioCardia, Inc. is a clinical-stage regenerative medicine company engaged in developing therapeutics for cardiovascular diseases. The Company's therapeutic portfolio consists of the CardiAMP and CardiALLO cell therapies. The Company's lead therapeutic candidate is the CardiAMP Cell Therapy System (CardiAMP) and focuses on the Phase III trial for CardiAMP in ischemic systolic heart failure. The Company's CardiALLO Cell Therapy System (CardiALLO), is an allogeneic off the shelf...
Simon Stertzer M.D.
Chairman
Peter Altman Ph.D.
President
David McClung CPA
Chief Financial Officer
Address
125 Shoreway Rd Ste B
San Carlos, CA
94070-2718
United States